TABLE 2.
β-Lactamase | Molecular classa | Antibacterial agent | kcat (s−1)b | Km or Ki (μM)b | kcat/Km (μM−1 s−1) |
---|---|---|---|---|---|
IMP-1 | B | S-649266c | 0.92 ± 0.0089 | 190 ± 19 | 0.0048 |
Meropenem | 6.5 ± 0.23 | 3.3 ± 1.2 | 2.0 | ||
Ceftazidime | 7.2 ± 0.24 | 55 ± 2.6 | 0.13 | ||
Cefepime | 10 ± 0.50 | 29 ± 2.6 | 0.34 | ||
Nitrocefin | 220 ± 33 | 2.6 ± 1.3 | 85 | ||
VIM-2 | B | S-649266c | 1.0 ± 0.019 | 200 ± 12 | 0.0050 |
Meropenem | 4.4 ± 0.27 | 2.4 ± 0.63 | 1.8 | ||
Ceftazidime | 3.3 ± 0.13 | 64 ± 1.1 | 0.052 | ||
Cefepimec | 49 ± 0.74 | 100 ± 9.3 | 0.49 | ||
Nitrocefin | 890 ± 6.3 | 4.9 ± 0.29 | 182 | ||
L1 | B | S-649266 | 12 ± 0.57 | 510 ± 64 | 0.024 |
Meropenem | 45 ± 1.6 | 7.1 ± 0.94 | 6.3 | ||
Ceftazidime | 71 ± 2.8 | 470 ± 33 | 0.15 | ||
Cefepimec | NDd | >500 | NCf | ||
Imipenem | 250 ± 8.5 | 60 ± 1.9 | 4.2 | ||
KPC-3 | A | S-649266 | NDe | >1,600 | NC |
Meropenem | 1.3 ± 0.035 | 6.5 ± 0.37 | 0.20 | ||
Ceftazidimec | NDd | 3,100 ± 520 | NC | ||
Cefepimec | 19 ± 0.058 | 350 ± 19 | 0.054 | ||
Nitrocefin | 47 ± 19 | 15 ± 7.6 | 3.1 | ||
OXA-23 | D | S-649266c | NH | 4,800 ± 1,100 | NC |
Meropenemc | NDe | 0.028 ± 0.0023 | NC | ||
Ceftazidimec | NH | 9,800 ± 270 | NC | ||
Cefepimec | NDd | 1,500 ± 170 | NC | ||
Nitrocefin | 350 ± 7.7 | 34 ± 4.9 | 10 |
Classification as described by Ambler (14).
Each kcat, Km, and Ki value is the mean ± standard deviation (SD) of three different measurements. ND, not determined; NH, no hydrolysis detected.
Ki values were obtained using 100 μM nitrocefin for IMP-1, VIM-2, KPC-3, and OXA-23 or 100 μM imipenem for L1 as a reporter substrate.
Hydrolysis was observed, but the Km or Ki value was too high to determine the kcat value.
Hydrolysis was too weak to determine the kcat value.
NC, not calculated.